Cargando…
Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
Background: Direct oral anticoagulants (DOACs) are the preferred anticoagulant drugs for the prevention of atrial fibrillation (AF)-related thromboembolic complications and for the treatment and the prevention of recurrences of venous thromboembolism (VTE). The evaluation of self-reported adverse dr...
Autores principales: | Lavalle, Carlo, Mariani, Marco Valerio, Piro, Agostino, Magnocavallo, Michele, Vetta, Giampaolo, Trivigno, Sara, Forleo, Giovanni Battista, Della Rocca, Domenico Giovanni, Uguccioni, Massimo, Russo, Vincenzo, Summaria, Francesco, Di Lullo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181424/ https://www.ncbi.nlm.nih.gov/pubmed/35683593 http://dx.doi.org/10.3390/jcm11113207 |
Ejemplares similares
-
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
por: Mariani, Marco Valerio, et al.
Publicado: (2020) -
Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives
por: Lavalle, Carlo, et al.
Publicado: (2021) -
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
por: Chimenti, Cristina, et al.
Publicado: (2021) -
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020) -
Catheter ablation for papillary muscle arrhythmias: A systematic review
por: Mariani, Marco Valerio, et al.
Publicado: (2022)